期刊论文详细信息
| Breast Cancer: Basic and Clinical Research | |
| Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2-Metastatic Breast Cancer | |
| Original Research | |
| Yan Song1 Alexander R. Macalalad1 James E. Signorovitch1 Peggy L. Lin1 Eric Q. Wu1 Yanni Hao2 | |
| [1] Analysis Group, Inc., Boston, MA, USA.;Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.; | |
| 关键词: breast cancer; chemotherapy; endocrine therapy; HR+/HER2– metastatic breast cancer; clinical outcomes; | |
| DOI : 10.4137/BCBCR.S30771 | |
| received in 2015-06-17, accepted in 2015-07-28, 发布年份 2015 | |
| 来源: Sage Journals | |
 PDF
|
|
【 授权许可】
CC BY-NC
© 2015 SAGE Publications.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202212206736610ZK.pdf | 1032KB |  download |
|
| Figure 1. | 36KB | Image | download |
| Table 1. | 99KB | Table | download |
| Figure 6. | 253KB | Image | download |
| Table 3. | 43KB | Table | download |
| Table 1 | 97KB | Table | download |
| Figure 7. | 1421KB | Image | download |
【 图 表 】
Figure 7.
Figure 6.
Figure 1.
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
878987797
028-85220240
